AlveoGene
PrivateLast Round
Seed
Sep 14, 2023
Company Overview
AlveoGene operates in Healthcare & Life Sciences and is based in Oxford. Its latest recorded funding round was a Seed round in September 2023.
AlveoGene is a biotechnology company developing inhaled gene therapies for rare and serious respiratory diseases using its proprietary InGenuiTy® lentiviral delivery platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AlveoGene Comparables
Compare AlveoGene with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Spirovant Sciences | 76% | |
| Krystal Biotech, Inc. | 70% | |
| 4DMT | 69% |
For institutional investors. Book with your work email.
AlveoGene Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
AlveoGene Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Oxford Science Enterprises | Seed |
| Old College Capital | Seed |
| Harrington Discovery Institute | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 41% MoM.
- Jan 6, 2026
Monthly visitors grew 206% MoM, reaching 594.
For institutional investors. Book with your work email.
AlveoGene Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about AlveoGene's valuation, stock price, and market status.
Is AlveoGene a public or private company?
AlveoGene is a private company.
What is the current stock price of AlveoGene?
AlveoGene is a private company, so its shares have no public market price. Caplight tracks AlveoGene's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is AlveoGene worth (valuation)?
Valuation information for AlveoGene is not publicly available.
Can I buy AlveoGene stock?
AlveoGene shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was AlveoGene's last funding round?
AlveoGene's most recent funding round was Seed on September 14, 2023.
Who are the main investors in AlveoGene?
Key investors in AlveoGene include Oxford Science Enterprises.
Will AlveoGene IPO soon?
No public IPO plans have been announced for AlveoGene.
How can I track AlveoGene secondary market activity?
Caplight tracks bids, offers, and trades in AlveoGene's shares on secondary markets.